Skip to main content

Advertisement

Log in

Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction: Autoantibodies in rheumatoid arthritis (RA) are useful both for diagnosis and prognosis. Antibodies directed against citrullinated antigens have recently been shown to predict development of RA as well as poor outcome in early arthritis. Data on their role in established RA is limited. We studied the association of various autoantibodies in RA with its severity. Materials and methods: A total of one hundred and twenty nine-patients with established RA was enrolled and sera were collected and stored at −70°C. Data regarding erosions, deformities, and extra-articular features were collected. IgM rheumatoid factor (RF) was measured using nephelometry and value above 20 U was considered positive. IgA RF was measured by enzyme-linked immunosorbent assay (ELISA) and value above the mean±2 SD of normal healthy control was taken as positive. Anti-keratin antibody (AKA) was detected by indirect immunofluorescence assay using rat esophagus as substrate. Anti-cyclic citrullinated peptide (CCP) antibodies were measured by commercial ELISA and a value above 5 U was considered as positive. Results: The prevalence of various autoantibodies was: IgM RF 82.2%, anti-CCP antibodies 82.2%, AKA 51.9%, and anti IgA RF 45%. The concordance rate of anti-CCP antibodies with IgM RF was 83%, with AKA 68%, and with IgA RF 60.5%. All but one patient positive for AKA were positive for anti-CCP antibodies. The presence of IgM RF, AKA, and anti-CCP antibody was associated with joint erosions and deformities. None of the antibodies had any association with presence of extra-articular features. No association of IgA RF was seen with erosions, deformities, or extra-articular features. Among 23 seronegative RA patients, 11 were positive for anti-CCP antibodies and 6 were AKA positive. The presence of anti-CCP antibodies was associated with presence of deformities (p<0.05). Conclusion: Anti-CCP antibodies are present in majority of patients with established RA including seronegative patients. Both anti-CCP and AKA, in addition to conventional marker like IgM RF, are associated with severe erosive disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Combe B, Eliaou JF, Daurès JP, Meyer O, Clot J, Sany J (1995) Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 34:529–534

    PubMed  CAS  Google Scholar 

  2. van der Heijde DM, van Riel PL, van Leuween MA, van’t Hof MA, van Rijswijk MH, van de Putte LBA (1992) Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: a prospective follow-up study of 147 patients. Br J Rheumatol 31:519–525

    PubMed  Google Scholar 

  3. Meyer O, Combe B, Elias A, Benali K, Clot J, Sany J, Eliaou JF (1997) Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Ann Rheum Dis 56:682–685

    Article  PubMed  CAS  Google Scholar 

  4. Berthelot JM, Maugars Y, Castagnè A, Audrain M, Prost A (1997) Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled. Ann Rheum Dis 56:123–125

    PubMed  CAS  Google Scholar 

  5. Kurki P, Aho K, Palosuo T, Heliovaara M (1992) Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede clinical disease. Arthritis Rheum 35:914–917

    PubMed  CAS  Google Scholar 

  6. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific autoantibodies. J Clin Invest 101:273–281

    PubMed  CAS  Google Scholar 

  7. Westgeest AA, Boerbooms AM, Jongmans M, Vandenbroucke JP, Vierwinden G, van De Putte LB (1987) Antiperinuclear factor: indicators of more severe disease in seronegative rheumatoid arthritis. J Rheumatol 14:893–897

    PubMed  CAS  Google Scholar 

  8. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M (1992) Antikeratin antibodies: diagnostic and prognostic markers of early rheumatoid arthritis. Ann Rheum Dis 51:743–746

    PubMed  CAS  Google Scholar 

  9. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B (2004) Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 63:1090–1095

    Article  PubMed  CAS  Google Scholar 

  10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    PubMed  CAS  Google Scholar 

  11. Bharadwaj A, Aggarwal Amita, Misra R (1999) Clinical relevance of IgA rheumatoid factor (RF) in children with juvenile rheumatoid arthritis. Rheumatol Int 19:47–49

    Article  PubMed  CAS  Google Scholar 

  12. Sharma BL, Rani R, Misra R, Aggarwal A (2000) Anti-keratin antibodies in patients with rheumatoid arthritis. Indian J Med Res 111:215–218

    PubMed  CAS  Google Scholar 

  13. Raza K, Breese M, Nightingale P, Kumar K, Potter T, Carruthers DM, Situnayake D, Gordon C, Buckley CD, Salmon M, Kitas GD (2005) Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 32:231–238

    PubMed  CAS  Google Scholar 

  14. Pruijn GJM, Vossenaar ER, Drijfhout JW, van Venrooij WJ, Zendman AJW (2005) Anti-CCP antibody detection facilitates early diagnosis and prognosis of rheumatoid arthritis. Curr Rheumatol Rev 1:1–7

    Article  CAS  Google Scholar 

  15. Vencovskỳ J, Machaèek S, Šedová L, Kafková J, Gatterová J, Pešáková V, Ruièková Š (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427–430

    Article  PubMed  Google Scholar 

  16. Meyer O, Labarre C, Dougados M, Goupille Ph, Acntagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B (2003) Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62:120–126

    Article  PubMed  CAS  Google Scholar 

  17. Furst DE (1994) Predictors of worsening clinical variables and outcomes in rheumatoid arthritis. Rheum Dis Clin North Am 20:309–319

    PubMed  CAS  Google Scholar 

  18. Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X (2003) Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology (Oxford) 42:939–946

    Article  CAS  Google Scholar 

  19. Teitsson I, Withrington RH, Seifert MH, Valdimarsson H (1984) Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis 43:673–678

    Article  PubMed  CAS  Google Scholar 

  20. Houssien DA, Choy EH, Carr AJ, Scott DL (1997) Rheumatoid arthritis (RA) outcome in routine practice: a comparison of outcome assessment. Arthritis Rheum 40:S152 (Suppl)

    Google Scholar 

  21. Eberhardt KB, Rydgren LC, Pettersson H, Wollheim FA (1990) Early rheumatoid arthritis—onset, course and outcome over 2 years. Rheumatol Int 10:135–142

    Article  PubMed  CAS  Google Scholar 

  22. Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677–680

    Article  PubMed  CAS  Google Scholar 

  23. De Rycke L, Peene I, Hoffman IEA, Kruithof E, Union A, Meheus L et al (2004) Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate and extra-articular manifestatations. Ann Rheum Dis 63:1587–1593

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amita Aggarwal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agrawal, S., Misra, R. & Aggarwal, A. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol 26, 201–204 (2007). https://doi.org/10.1007/s10067-006-0275-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0275-5

Keywords

Navigation